US Patent 7462612 Pyridine inhibitors of ERK2 and uses thereof
Patent 7462612 was granted and assigned to Vertex Pharmaceuticals on December, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Gabriel Martinez-Botella0
Michael Hale0
Qing Tang0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+294 characters)
Article
Patent abstract
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07462612 Pyridine inhibitors of ERK2 and uses thereof US Patent 7462612 Pyridine inhibitors of ERK2 and uses thereof
Infobox
Patent Number
07462612
Patent Number
7462612
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07462612 Pyridine inhibitors of ERK2 and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07462612
Date of patent
December 9, 2008
Patent application number
11089701
Date Filed
March 25, 2005
Patent primary examiner
Find more entities like US Patent 7462612 Pyridine inhibitors of ERK2 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
